Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-30

Clinical Trial Update: Examining Physiology and Brain Function in People With the Fragile X Premutation

View source ↗

Summary

This clinical trial update describes a completed study led by UC Davis that examined physiology and brain function in people with the Fragile X Premutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Davis | Conditions: Fragile X Premutation | Status: COMPLETED